B

BridgeBio Oncology Therapeutics Inc
D

BBOT

4.65500
USD
-0.10
(-2.00%)
Post Trading·4.59000USD-0.06500(-1.40%)
حجم التداول
9,594
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
373,211,213
المقالات
المزيد

العنوان: BridgeBio Oncology Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.